Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Hangzhou Endonom Medtech Co., Ltd.

ClinicalTrials.gov lists Hangzhou Endonom Medtech Co., Ltd. as lead sponsor of 17 trials. It has 1 active development program.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

4 0 2017 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.0 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Hangzhou Endonom Medtech Co., Ltd.: 17 lead-sponsored trials and 0 legal-entity registrations.

Get the Hangzhou Endonom Medtech Co., Ltd. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (5)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Aortic Dissection 5
Aneurysm, Aortic Arch 2
Aortic Aneurysm 2
Aortic Aneurysm, Thoracic 2
Ulcer 1

Trials by start year as sponsor or collaborator (9)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 2
2025 1
2024 1
2023 4
2022 2
2021 2
2020 1
2019 3
2017 1

Prediction, not a registry value: median of 31 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 35 months across 5 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (1)

Active development programs
Drug Disease area Max phase Trials
Conventional Treatment group Aortic Dissection Not reported 1

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
4 of 4 hit target (n=4) 1 of 3 on time (n=3)

Journals published in (11)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2
Annals of vascular surgery 1
BMJ open 1
Circulation 1
European heart journal 1

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
5 5 2023-08-01

Latest dated events (22)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07-13 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-06-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-09-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-06-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-10-24 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.